
About this episode
Eric Puro is the Founder & CEO of KÄÄPÄ Biotech, a Finnish biotechnology company that researches, innovates, and develops novel industry solutions by leveraging the genius of fungi.
Since launching in 2016, KÄÄPÄ has established itself as a major player on the mycopreneurial world stage - In addition to securing Chinese and North American distribution agreements and establishing a forest sciences branch, Eric and his team maintain the largest Chaga cultivation network on the planet.
In today's episode, we dive into:
The origin story of KÄÄPÄ and why they still hold company meetings in saunas
KÄÄPÄ's ongoing Series A funding round and what the company will do with their injection of capital
The reclassification of Turkey Tail fungi as a Novel Food in the European Union
Why Mycopreneurs shouldn't be competing against each other
Mushroom traditions of the Sami people in Northern Finland, the only indigenous people living within EU territory
and more
Please rate and review the episode where've you're listening to it
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Mycopreneur publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mycopreneur

Lee Carroll: Ergothioneine in Support of Psychedelic Therapy
Mycopreneur

Adam Miezio: Psychedelics in the Epstein Files
Mycopreneur

Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries
Mycopreneur

Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims
Mycopreneur